The Wall Street Journal Health Blog reports that many top people at Merck will keep their positions as the merger with Schering-Plough goes through. Merck's CEO, Dick Clark, will stay in charge. Also keeping their spots are Kenneth Frazier, the head of global human health, Peter Kim, the head of research labs, and Willie Deese, the head of manufacturing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.